Dr Icro Meattini speaks to ecancer at the 2019 San Antonio Breast Cancer Symposium about the effectiveness of partial breast irradiation (APBI) compared to whole breast irradiation (WBI) in patients with early breast cancer.
He gives an overview of the study which provides a ten-year update and will primarily measure the ipsilateral breast tumour recurrence.
Dr Meattini reports the main findings, which confirmed the previous results from the five-year update. There was no significant difference between the two arms of the study, and APBI produced excellent disease control with a favourable toxicity profile.
He discusses the clinical impact of these results and how clinicians should decide which technique to use.
Watch the press conference here.
Read more about the study here.